Track topics on Twitter Track topics that are important to you
Veryan has developed three dimensional (3D) stent technology based upon a helical shape that may be applied to a self-expanding stent platform. The initial objective was to investigate the presen...
Brilinta - ticagrelor, AstraZeneca's new heart drug is a blood-thinning medicine designed to prevent dangerous blood clots in patients with serious chest pain or previous heart attacks. It re...
Aorfix™ endovascular stent graft – Treating the cases other grafts cannot treat Aorfix™ is the only endovascular stent graft licensed in Europe to treat aneurysms in complex anat...
A dissolvable heart stent developed by Abbott Pharmaceuticals performed similarly to a conventional stent in a human clinical trial. But that might not make it better.
A 2,000-patient multisite study showed promising results for Abbott's Absorb, a heart stent that dissolves completely. -More-
A recall involving 29 units of SynCardia Systems' Total Artificial Heart Freedom Driver system has been categorized by the FD -More-
Now you see it, now you don't. A new type of heart stent that works like dissolving stitches, slowly going away after it has done its job, passed its first major test in a large study, doctors said Mo...
Abbott announced today positive one-year clinical results from the ABSORB 3 trial, which compared the safety and effectiveness of Abbott's fully dissolving Absorb heart stent to Xience, Abbott's mark...
Oct 12 (Reuters) - A novel dissolving heart stent developed by Abbott Laboratories proved comparably safe and effective as its market-leading Xience stent in a large, late-stage trial that will be use...
(Reuters) - A novel dissolving heart stent developed by Abbott Laboratories proved comparably safe and effective as its market-leading Xience stent in a large, late-stage trial that will be used to se...
(Reuters) - Medtronic Plc will recall 6,912 units of the loading system of a recently approved heart device after reports of the presence of particulates, the U.S. Food and Drug Administration said.
This study sought to assess the incidence and clinical impact of stent fracture (SF) after the PROMUS Element platinum-chromium everolimus-eluting stent (PtCr-EES).
Rupture-prone plaques in the coronary arteries, called ``vulnerable plaques'', are recognized as the key factor in acute myocardial infarction. Vulnerable plaques have a thin fibrous cap over a large ...
Fibrin deposition and absent endothelium characterize unhealed stents that are at heightened risk of stent thrombosis. Optical coherence tomography (OCT) is increasingly used for assessing stent tissu...
Drug-eluting stents (DES) reduce restenosis, as compared with bare-metal stents (BMS); however, the relationship between stent type and health status is unknown. We examined whether stent type was ass...
Histopathological evaluation of thrombus in patients presenting with stent thrombosis. A multicenter European study: a report of the prevention of late stent thrombosis by an interdisciplinary global European effort consortium†.
Stent thrombosis (ST) is a rare but serious complication following percutaneous coronary intervention. Analysis of thrombus composition from patients undergoing catheter thrombectomy may provide impor...